$479.3M in CY2024 Part D spend14.9M claims · 4.2M beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Bupropion used for?
Bupropion hydrochloride extended-release tablets (XL) are an aminoketone antidepressant, indicated for: treatment of major depressive disorder (MDD) (1.1) prevention of seasonal affective disorder ....
Is there a generic for Bupropion?
Yes. 75 ANDAs filed at FDA, 26 generic manufacturers currently shipping.
How much does my plan pay for Bupropion?
Across 329 Part D plans, Bupropion averages $0.068/unit (NADAC). Lowest available: $0.068/unit. Highest in distribution: $0.068/unit.
Is Bupropion on the FDA shortage list?
No. Bupropion is not currently on the FDA Drug Shortage Database.
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.